The goal of this study was to investigate the prevalence of LS and non-LS mutations and the relative contribution of each MMR gene mutation that, in composite, led to the clinical phenotype of LS-associated endometrial cancer patients in a predominantly Korean population. This evidence concerns the gene MRC1 and endometrial cancer.